What is the recommended management of headache in a patient following a hemorrhagic stroke?

Management of Headache Following Hemorrhagic Stroke

Acetaminophen is the first-line agent for post-hemorrhagic stroke headache, with opioids reserved for refractory cases; avoid routine use of corticosteroids or antiseizure medications for headache management alone. 1

Acute Phase Management (First 24-48 Hours)

Initial Assessment and Stabilization

• Severe headache after hemorrhagic stroke requires immediate exclusion of re-bleeding or hydrocephalus through non-contrast head CT, particularly if headache worsens or new neurological deficits develop. 2
• Blood pressure control is critical in the acute phase with unsecured aneurysms; maintain systolic BP around 140 mmHg using titratable agents to balance re-bleeding risk against cerebral perfusion. 2
• Nimodipine must be initiated within 96 hours of hemorrhage onset and continued for 14-21 days—this is the only therapy proven to improve neurological outcomes after subarachnoid hemorrhage. 2

Analgesic Approach During Hospitalization

• Acetaminophen (paracetamol) is the most commonly used first-line agent, prescribed by 90% of providers managing hemorrhagic stroke patients. 1
• Opioids are used by 66% of providers and perceived as most effective by 39% of intensivists, though they carry significant risks of respiratory depression, constipation, and dependency. 1
• Avoid routine use of corticosteroids (used by only 28% of providers) or antiseizure medications (28%) specifically for headache management unless other indications exist, as evidence for efficacy is limited. 1

Subacute and Chronic Management (Beyond 3 Months)

Persistent Post-Stroke Headache Recognition

• Persistent post-hemorrhagic stroke headache (PPSH) affects up to 23% of patients and is defined as headache developing in close temporal relation to stroke that persists beyond 3 months. 3, 4
• These headaches typically present with tension-type features rather than the severe "thunderclap" quality of acute hemorrhage. 3
• Risk factors include younger age, female sex, pre-existing headache disorders, and comorbid post-stroke depression or fatigue. 3

Treatment Strategy Based on Headache Phenotype

• For tension-type features (most common): Start with acetaminophen or NSAIDs if not contraindicated by bleeding risk; consider tricyclic antidepressants or muscle relaxants for prophylaxis. 3
• For migraine-like features: NSAIDs or acetaminophen remain first-line; triptans may be considered cautiously in selected patients remote from hemorrhage, though safety data are limited. 5
• Avoid opioids and butalbital for chronic management due to risk of medication overuse headache and dependency. 5

Novel Therapeutic Options

• CGRP receptor antagonists (erenumab) have shown promise in case reports for refractory persistent post-hemorrhagic stroke headache, reducing frequency from daily to 1-2 times monthly. 6
• This represents an emerging treatment option when conventional therapies fail, though more evidence is needed. 6

Critical Management Pitfalls

• Responsibility gaps: Intensive care teams typically manage analgesia during hospitalization (57%), but responsibility shifts to neurosurgery at discharge (47%), creating potential discontinuity in headache management. 1
• Opioid overreliance: Despite the opioid crisis, 69% of providers report no change in opioid prescription patterns for post-hemorrhagic stroke headache. 1
• Discharge prescribing: At discharge, acetaminophen (80%) and opioids (46%) are most commonly prescribed, with significant geographic variation—opioids prescribed more frequently in North America than Europe. 1
• Missed secondary causes: Always reassess for hydrocephalus, re-bleeding, or vasospasm if headache pattern changes or neurological status deteriorates. 2

Monitoring and Follow-Up

• Establish clear handoff protocols between intensive care, neurosurgery, and outpatient providers to ensure continuity of headache management. 1
• Screen for contributing factors including obstructive sleep apnea, musculoskeletal imbalances, depression, and medication overuse. 3
• Consider neurology or headache specialist referral for headaches persisting beyond 3 months that are refractory to initial management. 3, 4